GRACEcast Lung Cancer Video

Follow GRACEcast Lung Cancer Video
Share on
Copy link to clipboard

Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.

cancerGRACE - H. Jack West, MD


    • Aug 23, 2016 LATEST EPISODE
    • infrequent NEW EPISODES
    • 7m AVG DURATION
    • 542 EPISODES


    More podcasts from cancerGRACE - H. Jack West, MD

    Search for episodes from GRACEcast Lung Cancer Video with a specific topic:

    Latest episodes from GRACEcast Lung Cancer Video

    Basics of Small Cell Lung Cancer

    Play Episode Listen Later Aug 23, 2016 4:55


    04:55 clean of,small,cell,cancer,basics,lung,sanborn,cancergrace Lung Cancer Video Library ASCO 2016 Rachel Sanborn Basics of Small Cell Lung Cancer west@cancergrace.org (cancerGRACE - H. Jack West, MD)cancerGRACE - H. Jack West, MDExpert oncologists provide brief, distilled summaries of the most central issues in cancer management and emerging approaches for patients and caregivers. The Global Resource for Advancing Cancer Education (GRACE) is committed to providing the knowledge that will help enable the general public to be informed participants in their own care. Visit CancerGRACE.org for more info.http://cancergrace.grace.libsynpro

    Adjuvant Chemotherapy for Elderly and Frail Patients

    Play Episode Listen Later Aug 23, 2016 6:30


    06:30 clean 2,video,for,early,rachel,library,cancer,part,elderly,stage,lung,chemotherapy,2016,patients,sanborn,cancergrace,nsclc,adjuvant,frail,asco Lung Cancer Video Library ASCO 2016 - Rachel Sanborn - Adjuvant Chemotherapy for Elderly and Frail Patients west@cancergrace.org (cancerGRACE - H. Jack West, MD)cancerGRACE - H. Jack West, MDExpert oncologists provide brief, distilled summaries of the most central issues in cancer management and emerging approaches for patients and caregivers. The Global Resource for Advancing Cancer Education (GRACE) is committed to providing the knowledge that will help enable the general public to be informed participants in their own care. Visit CancerGRACE.org for more info.

    Rachel Sanborn - Adjuvant Chemotherapy for Early Stage NSCLC Patients, part 1

    Play Episode Listen Later Aug 22, 2016 5:28


    05:28 clean 1,video,for,early,rachel,library,cancer,part,stage,lung,chemotherapy,patients,sanborn,nsclc,adjuvant Lung Cancer Video Library - Rachel Sanborn - Adjuvant Chemotherapy for Early Stage NSCLC Patients, part 1 west@cancergrace.org (cancerGRACE - H. Jack West, MD)cancerGRACE - H. Jack West, MDExpert oncologists provide brief, distilled summaries of the most central issues in cancer management and emerging approaches for patients and caregivers. The Global Resource for Advancing Cancer Education (GRACE) is committed to providing the knowledge that will help enable the general public to be informed participants in their own care. Visit CancerGRACE.org for more

    New Trials of Targeting Therapies to Treat Leptomeningeal Carcinomatosis

    Play Episode Listen Later Aug 11, 2016 4:31


    GRACE is happy to present the 8th in our series ASCO 2016 Lung Cancer Roundtable, Highlights and New Approaches in Lung Cancer.  Featuring Jack West, MD, Janet Freeman-Daily, Everett Vokes, MD, and Suresh Ramalingam, MD, this roundtable discussion, moderated by Dr. West, highlights the newest and most intriguing discussions from ASCO 2016. Drs. West, Vokes and Ramalingam, along with patient advocate Janet Freeman-Daily, discuss new trials of targeting therapies used to treat leptomeningeal carcinomatosis.

    ASCO 2016 LC RT Vid 8 - Promising Early Results for Treatments

    Play Episode Listen Later Aug 11, 2016 4:59


    GRACE is happy to present the 8th in our series ASCO 2016 Lung Cancer Roundtable, Highlights and New Approaches in Lung Cancer.  Featuring Jack West, MD, Janet Freeman-Daily, Everett Vokes, MD, and Suresh Ramalingam, MD, this roundtable discussion, moderated by Dr. West, highlights the newest and most intriguing discussions from ASCO 2016. Drs. West, Vokes and Ramalingam, along with patient advocate Janet Freeman-Daily, discuss promising early results for treatments targeting new mutations.

    Immuno-oncology Developments - Combinations and Use as First-Line Therapy

    Play Episode Listen Later Aug 10, 2016 7:11


    GRACE is happy to present the 6th in our series ASCO 2016 Lung Cancer Roundtable, Highlights and New Approaches in Lung Cancer.  Featuring Jack West, MD, Janet Freeman-Daily, Everett Vokes, MD, and Suresh Ramalingam, MD, this roundtable discussion, moderated by Dr. West, highlights the newest and most intriguing discussions from ASCO 2016. Drs. West, Vokes and Ramalingam, along with patient advocate Janet Freeman-Daily, discuss Immuno-oncology developments - combinations and use as first-Line therapy.

    Does Current Evidence Support Favoring Proton-Beam Radiation

    Play Episode Listen Later Aug 4, 2016 8:36


    GRACE is happy to present the 6th video in our series ASCO 2016 Lung Cancer Roundtable, Highlights and New Approaches in Lung Cancer.  Featuring Jack West, MD, Janet Freeman-Daily, Everett Vokes, MD, and Suresh Ramalingam, MD, this roundtable discussion, moderated by Dr. West, highlights the newest and most intriguing discussions from ASCO 2016.   Drs. West, Vokes and Ramalingam, along with patient advocate Janet Freeman-Daily, discuss whether current evidence supports favoring proton beam radiation.

    J-Alex Trial: Should Alecensa Replace Xalkori as First-Line ALK Therapy?

    Play Episode Listen Later Aug 4, 2016 11:02


    GRACE is happy to present the 5th in our series ASCO 2016 Lung Cancer Roundtable, Highlights and New Approaches in Lung Cancer.  Featuring Jack West, MD, Janet Freeman-Daily, Everett Vokes, MD, and Suresh Ramalingam, MD, this roundtable discussion, moderated by Dr. West, highlights the newest and most intriguing discussions from ASCO 2016. Drs. West, Vokes and Ramalingam, along with patient advocate Janet Freeman-Daily, discuss the J-Alex trial and whether Alecensa should replace Xalkori as First-Line ALK Therapy.

    Local Consolidation Therapies for Oligomatastases

    Play Episode Listen Later Jul 18, 2016


    GRACE is happy to present the 4th in our series ASCO 2016 Lung Cancer Roundtable, Highlights and New Approaches in Lung Cancer.  Featuring Jack West, MD, Janet Freeman-Daily, Everett Vokes, MD, and Suresh Ramalingam, MD, this roundtable discussion, moderated by Dr. West, highlights the newest and most intriguing discussions from ASCO 2016. Drs. West, Vokes and Ramalingam, along with patient advocate Janet Freeman-Daily, discuss the subject of local consolidation therapies for oligomatastases.

    Urine or Blood Testing Instead of Lung Biopsy Shows Promise for Finding EGFR Mutations

    Play Episode Listen Later Jul 13, 2016 8:29


    GRACE is happy to present our ASCO 2016 Lung Cancer Roundtable series, Highlights and New Approaches in Lung Cancer.  Featuring Jack West, MD, Janet Freeman-Daily, Everett Vokes, MD, and Suresh Ramalingam, MD, this roundtable discussion, moderated by Dr. West, highlights the newest and most intriguing topics presented at ASCO 2016. Drs. West, Vokes and Ramalingam, along with patient advocate Janet Freeman-Daily, discuss the subject of urine or blood testing instead of lung biopsy, showing promise for finding EGFR mutations.     

    Can Online Patient Groups Speed New Targeted Therapies?

    Play Episode Listen Later Jul 7, 2016 4:47


    GRACE is happy to present our ASCO 2016 Lung Cancer Roundtable series, Highlights and New Approaches in Lung Cancer.  Featuring Jack West, MD, Janet Freeman-Daily, Everett Vokes, MD, and Suresh Ramalingam, MD, this roundtable discussion, moderated by Dr. West, highlights the newest and most intriguing topics presented at ASCO 2016. Drs. West, Vokes and Ramalingam, along with patient advocate Janet Freeman-Daily, discuss the subject of online patient groups and if they can help speed the development of new targeted therapies.  A subject quite important to online groups such as our own GRACE.

    Rova-T Shows Promise in Small Cell Lung Cancer

    Play Episode Listen Later Jul 6, 2016 4:58


    1st Video in the GRACE ASCO 2016 Lung Cancer Roundtable series, featuring Jack West, MD, Janet Freeman-Daily, Everett Vokes, MD, and Suresh Ramalingam, MD.  Dr. West moderates this roundtable discussion highlighting studies presented at ASCO 2016.  For this video, Rova-T is presented as showing promise in Small Cell Lung Cancer. 

    Immunotherapy as First-Line Treatment

    Play Episode Listen Later Apr 26, 2016 3:46


    Dr. Jack West, Swedish Cancer Institute, raises the question of whether to use immune checkpoint inhibitors as first-line treatment of lung cancer, alone or in combination with chemotherapy.

    Lung Cancer Screening - Process and Potential Benefits

    Play Episode Listen Later Apr 25, 2016 6:19


    Dr. Jed Gorden, Swedish Cancer Institute, reviews the lung cancer screening process, including low-dose CT scanning, smoking cessation, follow-up testing and counseling, and describes the potential benefits.

    Bronchoscopy and EBUS

    Play Episode Listen Later Apr 24, 2016 5:54


    Dr. Jed Gorden, Swedish Cancer Institute, describes the differences between bronchoscopy and endobronchial ultrasound, highlighting the advantages of EBUS in diagnosis and staging.

    Maintenance Therapy for Advanced NSCLC

    Play Episode Listen Later Apr 21, 2016 4:35


    Rociletinib/Osimertinib for EGFR T790M-negative NSCLC

    Play Episode Listen Later Apr 20, 2016 5:20


    Dr. Jack West, Swedish Cancer Institute, reviews trial evidence for the efficacy of rociletinib and osimertinib for EGFR acquired resistance not driven by a T790M mutation.

    Are There Clinically Significant Distinctions Between PD-1 and PD-L1?

    Play Episode Listen Later Apr 19, 2016 3:29


    Histology-Specific Recommendations - Large-Cell Neuroendocrine

    Play Episode Listen Later Apr 18, 2016 2:24


    Dr. Jack West, Swedish Cancer Institute, identifies the best choice for first-line chemotherapy for large-cell neuroendocrine histology.

    Histology-Specific Regimens - Squamous

    Play Episode Listen Later Apr 17, 2016 4:02


    Histology-Specific Regimens - Adenocarcinoma

    Play Episode Listen Later Apr 16, 2016 2:53


    What is the Role of Bevacizumab in Stage IV NSCLC?

    Play Episode Listen Later Apr 15, 2016 3:46


    Dr. Jack West, Swedish Cancer Institute, discusses the anti-angiogenic agent bevacizumab (Avastin) and the trial evidence of its efficacy for non-squamous NSCLC.

    Platinum-Based Chemo Doublets: Backbone for NSCLC Treatment

    Play Episode Listen Later Apr 14, 2016 3:40


    Timing of Second Generation ALK Inhibitors: First Line vs. Treatment after Acquired Resistance

    Play Episode Listen Later Apr 13, 2016 2:20


    Dr. Ross Camidge, University of Colorado, addresses the question of whether to use a second generation ALK inhibitor as first line therapy or only after acquired resistance to crizotinib.

    CNS Disease in ALK-Positive NSCLC: Monitoring and Systemic vs. Radiation Therapy

    Play Episode Listen Later Apr 12, 2016 2:30


    Dr. Ross Camidge, University of Colorado, discusses management of CNS progression for ALK-positive NSCLC including monitoring frequency and preferences between systemic and radiation therapy.

    Ceritinib and Other Second Generation ALK Inhibitors for Acquired Resistance in ALK-Positive NSCLC

    Play Episode Listen Later Apr 11, 2016 2:00


    Dr. Ross Camidge, University of Colorado, describes the second generation ALK-inhibitors which provide good options for ALK-positive NSCLC patients who have developed acquired resistance to crizotinib.

    Crizotinib for First Line Treatment of ALK or ROS1 Rearrangements

    Play Episode Listen Later Apr 10, 2016 0:56


    Dr. Ross Camidge, University of Colorado, explains the preference for crizotinib rather than platinum doublet chemotherapy as first line treatment for patients with ALK or ROS1 rearrangements.

    ROS-1 Rearrangements: What Are They?

    Play Episode Listen Later Apr 9, 2016 1:53


    Dr. Ross Camidge, University of Colorado, describes ROS-1 rearrangements and compares them to ALK rearrangements in frequency of occurrence and response to treatment.

    ALK Rearrangements: What Are They, and Who Has Them?

    Play Episode Listen Later Apr 8, 2016 1:47


    Dr. Ross Camidge, University of Colorado, describes ALK rearrangements and the characteristics of patients who most often have them.

    Multiplex Testing for Rare Mutations: What Are the Potential Benefits?

    Play Episode Listen Later Apr 7, 2016 2:56


    Dr. Ross Camidge, University of Colorado, discusses the potential benefits as well as the disadvantages of multiplex mutation testing.

    The Role of Targeted Therapy Post-Resection

    Play Episode Listen Later Apr 6, 2016 4:36


    Dr. Heather Wakelee, Stanford University Medical Center, evaluates the lack of evidence for the use of targeted therapies after surgery, and describes ongoing trials attempting to resolve that issue.

    What Is a Standard Adjuvant Chemotherapy Regimen?

    Play Episode Listen Later Apr 5, 2016 4:35


    Dr. Heather Wakelee, Stanford University Medical Center, lists standard adjuvant chemotherapy regimens, comparing their administration and uses.

    Why Give Adjuvant Chemotherapy, and to Which Patients?

    Play Episode Listen Later Apr 4, 2016 2:26


    Dr. Heather Wakelee, Stanford University Medical Center, discusses the purpose of adjuvant chemotherapy, and which patients benefit most from it.

    Zoledronate or Denosumab for Lung Cancer with Bone Metastases

    Play Episode Listen Later Mar 31, 2016 3:08


    Dr. Benjamin Levy, Mount Sinai Health Systems, compares zoledronic acid and denosumab, two agents used for treatment of bone metastases in lung cancer.

    Platinum-Based Doublets As the Cornerstone of First Line Treatment

    Play Episode Listen Later Mar 29, 2016 3:17


    Dr. Benjamin Levy, Mount Sinai Health Systems, discusses platinum-based chemotherapy as the standard of care for advanced NSCLC patients without targetable genetic mutations.

    What are the Goals of Treating Advanced NSCLC?

    Play Episode Listen Later Mar 28, 2016 2:51


    Dr. Benjamin Levy, Mount Sinai Health Systems, lists the goals of treating advanced NSCLC and the methods used to achieve those goals.

    Video-Assisted Thorascopic Surgery vs. Open Thoracotomy

    Play Episode Listen Later Mar 28, 2016 4:40


    Dr. David Harpole, Duke University Medical Center, compares traditional open thoracotomy with video-assisted thorascopic surgery, highlighting the advantages of the newer approach.

    What Is the Significance of Mediastinal Node Sterilization After Neoadjuvant Therapy?

    Play Episode Listen Later Mar 25, 2016 2:27


    Dr. David Harpole, Duke University Medical Center, defines the concept of mediastinal node sterilization and its use after neoadjuvant therapy.

    What Is a Sleeve Resection?

    Play Episode Listen Later Mar 24, 2016 2:15


    Dr. David Harpole, Duke University Medical Center, describes the sleeve resection and how it can help selected patients with large tumors retain lung function.

    What Is a Mediastinoscopy?

    Play Episode Listen Later Mar 23, 2016 2:28


    Dr. David Harpole, Duke University Medical Center, describes the mediastinoscopy and its use in lung cancer staging.

    Claim GRACEcast Lung Cancer Video

    In order to claim this podcast we'll send an email to with a verification link. Simply click the link and you will be able to edit tags, request a refresh, and other features to take control of your podcast page!

    Claim Cancel